Work

Supplementary Figure S1 from Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figure S1 shows that enhanced virus replication by combination treatment with oHSV and OS2966 significantly increases tumor necrosis in mammary fat-pad injected MDA468 tumor bearing mice.

DOI: 10.1158/1535-7163.22506454.v1

Authors: Tae Jin Lee, Mitra Nair, Yeshavanth Banasavadi-Siddegowda, Joseph Liu, Tejaswini Nallanagulagari, Alena Cristina Jaime-Ramirez, Jeffrey Yunhua Guo, Haroon Quadri, Jianying Zhang, Kurt H. Bockhorst, Manish K. Aghi, W. Shawn Carbonell, Balveen Kaur, Ji Young Yoo

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362534692

Cites:

Cited by:

Related to: 10